The Chemours Company (NYSE:CC) Shares Sold by Private Management Group Inc.

Private Management Group Inc. lowered its position in The Chemours Company (NYSE:CCFree Report) by 24.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 269,570 shares of the specialty chemicals company’s stock after selling 89,070 shares during the quarter. Private Management Group Inc.’s holdings in Chemours were worth $8,502,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Legacy Financial Group LLC acquired a new position in shares of Chemours during the third quarter valued at approximately $29,000. Morton Brown Family Wealth LLC acquired a new position in shares of Chemours during the fourth quarter valued at approximately $35,000. Anchor Investment Management LLC acquired a new position in shares of Chemours during the fourth quarter valued at approximately $56,000. Geneos Wealth Management Inc. increased its stake in shares of Chemours by 116.4% during the fourth quarter. Geneos Wealth Management Inc. now owns 1,859 shares of the specialty chemicals company’s stock valued at $59,000 after acquiring an additional 1,000 shares during the period. Finally, IFP Advisors Inc increased its stake in shares of Chemours by 39.0% during the third quarter. IFP Advisors Inc now owns 2,232 shares of the specialty chemicals company’s stock valued at $63,000 after acquiring an additional 626 shares during the period. Institutional investors and hedge funds own 76.26% of the company’s stock.

Chemours Trading Up 1.3 %

Chemours stock traded up $0.35 during midday trading on Wednesday, reaching $27.08. The stock had a trading volume of 1,039,608 shares, compared to its average volume of 1,858,605. The firm’s fifty day simple moving average is $26.72 and its two-hundred day simple moving average is $27.80. The Chemours Company has a twelve month low of $15.10 and a twelve month high of $39.05. The company has a current ratio of 1.54, a quick ratio of 1.00 and a debt-to-equity ratio of 5.40.

Chemours (NYSE:CCGet Free Report) last posted its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. The firm had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.37 billion. As a group, sell-side analysts anticipate that The Chemours Company will post 2.23 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 3.69%. The ex-dividend date was Friday, February 23rd. Chemours’s dividend payout ratio is -64.52%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. BMO Capital Markets upgraded shares of Chemours from an “underperform” rating to an “outperform” rating and raised their price objective for the company from $19.00 to $34.00 in a research note on Tuesday, April 9th. Barclays reduced their target price on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a report on Tuesday, April 2nd. Finally, UBS Group raised their target price on shares of Chemours from $21.00 to $28.00 and gave the stock a “neutral” rating in a report on Tuesday, April 2nd. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $30.89.

Check Out Our Latest Research Report on Chemours

Chemours Company Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Featured Stories

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.